scholarly journals Evaluating feasibility and satisfaction of a group intervention for mild cognitive impairment in older age bipolar disorder: “Brain train”

2021 ◽  
Author(s):  
Sigfried N. T. M. Schouws ◽  
Melis Orhan ◽  
Nicole Korten ◽  
Susan Zyto ◽  
Aartjan T. F. Beekman ◽  
...  
Keyword(s):  
Bipolar Disorder ◽  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Group Intervention ◽  
Older Age

scholarly journals Prevalence of Mild Cognitive Impairment in Mexican Older Adults: Data from the Mexican Health and Aging Study (MHAS)

2020 ◽  
Author(s):  
Miguel Arce Rentería ◽  
Jennifer J. Manly ◽  
Jet M. J. Vonk ◽  
Silvia Mejia Arango ◽  
Alejandra Michaels Obregon ◽  
...  
Keyword(s):  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Memory Impairment ◽  
Older Age ◽  
Mexican Population ◽  
Prevalence Rates ◽  
Amnestic Mci ◽  
Low Education ◽  
Health Factors ◽  
Aging Study

ABSTRACTINTRODUCTIONWe estimated the prevalence and risk factors for mild cognitive impairment (MCI) and its subtypes in Mexican population using the cognitive aging ancillary study of the Mexican Health and Aging Study.METHODSUsing a robust norms approach and comprehensive neuropsychological criteria, we determined MCI in a sample of adult Mexicans (N=1,807;55-97years). Additionally, we determined prevalence rates using traditional criteria.RESULTSPrevalence of amnestic MCI was 5.9%. Other MCI subtypes ranged 4.3% to 7.7%. MCI with and without memory impairment was associated with older age and rurality. Depression, diabetes and low educational attainment were associated with MCI without memory impairment. Using traditional criteria, prevalence of MCI was lower (2.2% amnestic MCI, other subtypes ranged 1.3%-2.4%).DISCUSSIONOlder age, depression, low education, diabetes, and rurality were associated with increased risk of MCI among older adults in Mexico. Our findings suggest that the causes of cognitive impairment are likely multifactorial and may vary by MCI subtype.Research in ContextSystematic reviewWe reviewed the literature using Google Scholar and PubMed. Few studies have reported prevalence rates for mild cognitive impairment (MCI) in Mexican population. These studies have primarily relied on limited cognitive assessments, and diverse MCI criteria. Evaluating the prevalence of MCI with a robust neuropsychological approach can help understand the rates and risk factors associated with MCI across a large and representative sample of the aging Mexican population.InterpretationVarious sociodemographic and health factors such as older age, depression, low education, diabetes, and rurality were significant correlates of MCI and differed by MCI subtype.Future directionsLongitudinal studies will be needed to evaluate the diagnostic stability of MCI over time, and its association with incident dementia. Future work will evaluate the casual path of these sociodemographic and health factors on cognitive impairment to develop effective interventions.

scholarly journals Treatment for mild cognitive impairment: systematic review

2013 ◽  
Vol 203 (4) ◽  
pp. 255-264 ◽  
Author(s):  
Claudia Cooper ◽  
Ryan Li ◽  
Constantine Lyketsos ◽  
Gill Livingston
Keyword(s):  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Group Intervention ◽  
Cholinesterase Inhibitors ◽  
National Football League ◽  
Life Quality ◽  
Preliminary Evidence ◽  
Jewish Federation ◽  
Incident Dementia ◽  
Randomised Controlled

BackgroundMore people are presenting with mild cognitive impairment (MCI), frequently a precursor to dementia, but we do not know how to reduce deterioration.AimsTo systematically review randomised controlled trials (RCTs) evaluating the effects of any intervention for MCI on cognitive, neuropsychiatric, functional, global outcomes, life quality or incident dementia.MethodWe reviewed 41 studies fitting predetermined criteria, assessed validity using a checklist, calculated standardised outcomes and prioritised primary outcome findings in placebo-controlled studies.ResultsThe strongest evidence was that cholinesterase inhibitors did not reduce incident dementia. Cognition improved in single trials of: a heterogeneous psychological group intervention over 6 months; piribedil, a dopamine agonist over 3 months; and donepezil over 48 weeks. Nicotine improved attention over 6 months. There was equivocal evidence that Huannao Yicong improved cognition and social functioning.ConclusionsThere was no replicated evidence that any intervention was effective. Cholinesterase inhibitors and rofecoxib are ineffective in preventing dementia. Further good-quality RCTs are needed and preliminary evidence suggests these should include trials of psychological group interventions and piribedil.Declarations of interestC.L. has received grant support (research or continuing medical education) from NIMH, NIA, Associated Jewish Federation of Baltimore, Weinberg Foundation, Forest, GlaxoSmithKline, Eisai, Pfizer, AstraZeneca, Lilly, Ortho-McNeil, Bristol-Myers Squibb, Novartis, National Football League (NFL), Elan, Functional Neuromodulation; and has been a consultant/advisor to AstraZeneca, GlaxoSmithKline, Eisai, Novartis, Forest, Supernus, Adlyfe, Takeda, Wyeth, Lundbeck, Merz, Lilly, Pfizer, Genentech, Elan, NFL Players Association, NFL Benefits Office, Avanir, Zinfandel, Bristol-Myers Squibb; and received honorarium or travel support from Pfizer, Forest, GlaxoSmithKline, Health Monitor.

Midlife Vascular Factors and Prevalence of Mild Cognitive Impairment in Late-Life in Mexico

2021 ◽  
pp. 1-11
Author(s):  
Miguel Arce Rentería ◽  
Jennifer J. Manly ◽  
Jet M.J. Vonk ◽  
Silvia Mejia Arango ◽  
Alejandra Michaels Obregon ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Rural Areas ◽  
Memory Impairment ◽  
Late Life ◽  
Older Age ◽  
Cognitive Domain ◽  
Urban And Rural Areas ◽  
The Impact

Abstract Objective: To estimate the prevalence of mild cognitive impairment (MCI) and its subtypes and investigate the impact of midlife cardiovascular risk factors on late-life MCI among the aging Mexican population. Method: Analyses included a sample of non-demented adults over the age of 55 living in both urban and rural areas of Mexico (N = 1807). MCI diagnosis was assigned based on a comprehensive cognitive assessment assessing the domains of memory, executive functioning, language, and visuospatial ability. The normative sample was selected by means of the robust norms approach. Cognitive impairment was defined by a 1.5-SD cut-off per cognitive domain using normative corrections for age, years of education, and sex. Risk factors included age, education, sex, rurality, depression, insurance status, workforce status, hypertension, diabetes, stroke, and heart disease. Results: The prevalence of amnestic MCI was 5.9%. Other MCI subtypes ranged from 4.2% to 7.7%. MCI with and without memory impairment was associated with older age (OR = 1.01 [1.01, 1.05]; OR = 1.03 [1.01, 1.04], respectively) and residing in rural areas (OR = 1.49 [1.08, 2.06]; OR = 1.35 [1.03, 1.77], respectively). Depression (OR = 1.07 [1.02, 1.12]), diabetes (OR = 1.37 [1.03, 1.82]), and years of education (OR = 0.94 [0.91, 0.97]) were associated with MCI without memory impairment. Midlife CVD increased the odds of MCI in late-life (OR = 1.76 [1.19, 2.59], which was driven by both midlife hypertension and diabetes (OR = 1.70 [1.18, 2.44]; OR = 1.88 [1.19, 2.97], respectively). Conclusions: Older age, depression, low education, rurality, and midlife hypertension and diabetes were associated with higher risk of late-life MCI among older adults in Mexico. Our findings suggest that the causes of cognitive impairment are multifactorial and vary by MCI subtype.

scholarly journals Olfactory Identification and Incidence of Mild Cognitive Impairment in Older Age

2007 ◽  
Vol 64 (7) ◽  
pp. 802 ◽  
Author(s):  
Robert S. Wilson ◽  
Julie A. Schneider ◽  
Steven E. Arnold ◽  
Yuxiao Tang ◽  
Patricia A. Boyle ◽  
...  
Keyword(s):  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Older Age ◽  
Olfactory Identification

scholarly journals Cingulum Microstructure Predicts Cognitive Control in Older Age and Mild Cognitive Impairment

2012 ◽  
Vol 32 (49) ◽  
pp. 17612-17619 ◽  
Author(s):  
C. Metzler-Baddeley ◽  
D. K. Jones ◽  
J. Steventon ◽  
L. Westacott ◽  
J. P. Aggleton ◽  
...  
Keyword(s):  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Cognitive Control ◽  
Older Age

Development of a psychosocial group intervention for individuals with mild cognitive impairment (innovative practice)

Dementia ◽  
2017 ◽  
Vol 19 (4) ◽  
pp. 1325-1332 ◽  
Author(s):  
Karen Barton ◽  
Ian Johnson ◽  
Amy Mountford
Keyword(s):  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Group Intervention ◽  
Well Being ◽  
Outcome Data ◽  
Anxiety And Depression ◽  
Recovery Model ◽  
Psychological Well Being ◽  
Innovative Practice

A diagnosis of mild cognitive impairment is associated with an increase in anxiety and depression and a decrease in psychological well-being. Despite this, individuals with mild cognitive impairment may not receive the appropriate support needed to manage the emotional and practical elements of their diagnosis. A psychosocial group intervention based on the ‘Recovery Model’ was developed in order to meet these needs. Outcome data from a trial of this group intervention indicated it was successful in meeting its aims.

Sign in / Sign up

Export Citation Format

Share Document